期刊文献+

Non-invasive determination of hepatic steatosis by acoustic structure quantification from ultrasound echo amplitude 被引量:15

Non-invasive determination of hepatic steatosis by acoustic structure quantification from ultrasound echo amplitude
下载PDF
导出
摘要 AIM:To use leptin-deficient(ob/ob) mice with demonstrated differences in steatosis levels to test a new diagnostic method using the acoustical structure quantification(ASQ) mode and the associated analytical parameter,"focal disturbance ratio"(FD-ratio).METHODS:Nine ob/ob mice,at 5,8,and 12 wk of age(n = 3 in each age group),were used as models for hepatic steatosis.Echo signals obtained from ultrasonography in the mice were analyzed by ASQ,which uses a statistical analysis of echo amplitude to estimate inhomogeneity in the diagnostic region.FD-ratio,as calculated from this analysis,was the focus of the present study.FD-ratio and fat droplet areas and sizes were compared between age groups.RESULTS:No fibrosis or inflammation was observed in any of the groups.The fat droplet area significantly(P < 0.01) increased with age from 1.25% ± 0.28% at 5 wk to 31.07% ± 0.48% at 8 wk to 51.69% ± 3.19% at 12 wk.The median fat droplet size also significantly(P < 0.01) increased with age,from 1.33(0.55-10.52) m at 5 wk,2.82(0.61-44.13) m at 8 wk and 6.34(0.66-81.83) m at 12 wk.The mean FD-ratio was 0.42 ± 0.11 at 5 wk,0.11 ± 0.05 at 8 wk,and 0.03 ± 0.02 at 12 wk.The FD-ratio was significantly lower at 12 wk than at 5 wk and 8 wk(P < 0.01).A significant negative correlation was observed between the FD-ratio and either the fat droplet area(r =-0.7211,P = 0.0017) or fat droplet size(r =-0.9811,P = 0.0052).CONCLUSION:This tool for statistical analysis of signals from ultrasonography using the FD-ratio can be used to accurately quantify fat in vivo in an animal model of hepatic steatosis,and may serve as a quantitative biomarker of hepatic steatosis. AIM:To use leptin-deficient(ob/ob) mice with demonstrated differences in steatosis levels to test a new diagnostic method using the acoustical structure quantification(ASQ) mode and the associated analytical parameter,"focal disturbance ratio"(FD-ratio).METHODS:Nine ob/ob mice,at 5,8,and 12 wk of age(n = 3 in each age group),were used as models for hepatic steatosis.Echo signals obtained from ultrasonography in the mice were analyzed by ASQ,which uses a statistical analysis of echo amplitude to estimate inhomogeneity in the diagnostic region.FD-ratio,as calculated from this analysis,was the focus of the present study.FD-ratio and fat droplet areas and sizes were compared between age groups.RESULTS:No fibrosis or inflammation was observed in any of the groups.The fat droplet area significantly(P 〈 0.01) increased with age from 1.25% ± 0.28% at 5 wk to 31.07% ± 0.48% at 8 wk to 51.69% ± 3.19% at 12 wk.The median fat droplet size also significantly(P 〈 0.01) increased with age,from 1.33(0.55-10.52) m at 5 wk,2.82(0.61-44.13) m at 8 wk and 6.34(0.66-81.83) m at 12 wk.The mean FD-ratio was 0.42 ± 0.11 at 5 wk,0.11 ± 0.05 at 8 wk,and 0.03 ± 0.02 at 12 wk.The FD-ratio was significantly lower at 12 wk than at 5 wk and 8 wk(P 〈 0.01).A significant negative correlation was observed between the FD-ratio and either the fat droplet area(r =-0.7211,P = 0.0017) or fat droplet size(r =-0.9811,P = 0.0052).CONCLUSION:This tool for statistical analysis of signals from ultrasonography using the FD-ratio can be used to accurately quantify fat in vivo in an animal model of hepatic steatosis,and may serve as a quantitative biomarker of hepatic steatosis.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2012年第29期3889-3895,共7页 世界胃肠病学杂志(英文版)
关键词 Non-alcoholic fatty liver disease Quantitation of hepatic steatosis Animal model Focal disturbance ratio Acoustic structure quantification Ultrasonography 超声信号 脂肪肝 回波幅度 声学结构 量化 侵入性 测定 诊断方法
  • 相关文献

参考文献24

  • 1Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp- Arida A, Yeh M, McCullough AJ, Sanyal AJ. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005; 41:1313-1321.
  • 2Harrison SA, Neuschwander-Tetri BA. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Clin Liver Dis 2004; 8: 861-79, ix.
  • 3Manco M, Marcellini M, Devito R, Comparcola D, Sartorelli MR, Nobili V. Metabolic syndrome and liver histology in paediatric non-alcoholic steatohepatitis. Int J Obes (Lond) 2008; 32:381-387.
  • 4Hamaguchi M, Kojima T, Takeda N, Nagata C, Takeda J, Sarui H, Kawahito Y, Yoshida N, Suetsugu A, Kato T, Oku- da J, Ida K, Yoshikawa T. Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease. World J Gastro- enterol 2007; 13:1579-1584.
  • 5Adams LA, Waters OR, Knuiman MW, Elliott RR, Olynyk JK. NAFLD as a risk factor for the development of diabe- tes and the metabolic syndrome: an eleven-year follow-up study. Am ] Gastroentero12009; 104:861-867.
  • 6Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto un- named disease. Mayo Clin Proc 1980; 55:434-438.
  • 7Cuadrado A, Orive A, Garcia-Surez C, Dominguez A, Fernndez-Escalante JC, Crespo J, Pons-Romero F. Non- alcoholic steatohepatitis (NASH) and hepatocellular carci- noma. Obes Surg 2005; 15:442-446.
  • 8Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 2006; 43:$99-$112.
  • 9Bugianesi E, Leone N, Vanni E, Marchesini G, Brunello F, Carucci P, Musso A, De Paolis P, Capussotti L, Salizzoni M, Rizzetto M. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology 2002; 123:134-140.
  • 10,jj Rafiq N, Bai C, Fang Y, Srishord M, McCullough A, Gram- lich T, Younossi ZM. Long-term follow-up of patients with nonalcoholic fatty liver. Clin Gastroenterol Hepatol 2009; 7: 234-238.

同被引文献78

  • 1Giovanni Tarantino,Carmine Finelli.What about non-alcoholic fatty liver disease as a new criterion to define metabolic syndrome?[J].World Journal of Gastroenterology,2013,19(22):3375-3384. 被引量:34
  • 2权启镇,谢宗贵,齐凤.胃冠状、胃短静脉栓塞术对胃底静脉曲张出血疗效评价[J].中华消化杂志,2005,25(2):87-89. 被引量:33
  • 3崔屹,李文欢.PTVE对门脉高压症食管胃底曲张血管破裂出血的疗效[J].山东医药,2006,46(10):1-2. 被引量:6
  • 4李雪芹,熊屏.超声检查在肝纤维化和肝硬化诊断中的应用[J].中西医结合肝病杂志,2006,16(3):188-190. 被引量:2
  • 5徐轶群,季成叶,马军,潘勇平,尹遵栋,张悦.超重、肥胖男青少年血清脂联素与转氨酶关系[J].中国公共卫生,2007,23(2):146-147. 被引量:5
  • 6Marno C. Ryan,Catherine Itsiopoulos,Tania Thodis,Glenn Ward,Nicholas Trost,Sophie Hofferberth,Kerin O’Dea,Paul V. Desmond,Nathan A. Johnson,Andrew M. Wilson.The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease[J].Journal of Hepatology.2013(1)
  • 7Seung Soo Lee,Seong Ho Park,Hye Jin Kim,So Yeon Kim,Min-Yeong Kim,Dae Yoon Kim,Dong Jin Suh,Kang Mo Kim,Mi Hyun Bae,Joo Yeon Lee,Sung-Gyu Lee,Eun Sil Yu.Non-invasive assessment of hepatic steatosis: Prospective comparison of the accuracy of imaging examinations[J].Journal of Hepatology.2010(4)
  • 8T.Yokoo,M.Shiehmorteza,G.Hamilton,T.Wolfson,M.E.Schroeder,M.S.Middleton,郭丽君.应用3.0 T MRI评价肝脏质子密度中脂肪含量[J].国际医学放射学杂志.2011(03)
  • 9Vincent Wai-Sun Wong,Ruth Suk-Mei Chan,Grace Lai-Hung Wong,Bernice Ho-Ki Cheung,Winnie Chiu-Wing Chu,David Ka-Wai Yeung,Angel Mei-Ling Chim,Jennifer Wing-Yan Lai,Liz Sin Li,Mandy Man-Mei Sea,Francis Ka-Leung Chan,Joseph Jao-Yiu Sung,Jean Woo,Henry Lik-Yuen Chan.Community-based lifestyle modification programme for non-alcoholic fatty liver disease: A randomized controlled trial&lt;!-- Doctopic: GMD --&gt;[J].Journal of Hepatology.2013
  • 10Nathan S. Artz,Catherine D.G. Hines,Stephen T. Brunner,Rashmi M. Agni,Jens-Peter Kühn,Alejandro Roldan-Alzate,Guang-Hong Chen,Scott B. Reeder.Quantification of Hepatic Steatosis With Dual-Energy Computed Tomography: Comparison With Tissue Reference Standards and Quantitative Magnetic Resonance Imaging in the ob/ob Mouse[J].Investigative Radiology.2012(10)

引证文献15

二级引证文献83

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部